DT402 (R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA))

Drug identity checked against registry records

Also recorded as MDMA; MM402; R-MDMA

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2A Trial of DT402 for Autism Spectrum DisorderNCT07303907Definium Therapeutics US, Inc.Phase 2Completed2026-09-16Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.